Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -73.97% is 34% below its 5-year average of -55.10%, near the high end of its 5-year range (-258.44%–-21.54%).
As of the fiscal period ended Tuesday, June 30, 2026. 21.03% below its 12-month average of -61.12%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -73.97%.
RETURN ON EQUITY (ROE)
-73.97%
RETURN ON EQUITY (ROE) AVG TTM
-61.12%
RETURN ON EQUITY (ROE) AVG 3Y
-57.38%
RETURN ON EQUITY (ROE) AVG 5Y
-55.10%
RETURN ON EQUITY (ROE) AVG 10Y
-47.42%
RETURN ON EQUITY (ROE) AVG 15Y
-32.97%
RETURN ON EQUITY (ROE) AVG 20Y
-26.73%
CURRENT VS TTM AVG
-21.03%
CURRENT VS 3Y AVG
-28.91%
CURRENT VS 5Y AVG
-34.25%
CURRENT VS 10Y AVG
-55.99%
CURRENT VS 15Y AVG
-124.34%
CURRENT VS 20Y AVG
-176.78%
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-96.42%
vs the sector median at left
Dyne Therapeutics, Inc.
Market Cap
$2.88B
Return on Equity (ROE)
-73.97%
TTM Avg
-61.12%
3Y Avg
-57.38%
5Y Avg
-55.10%
Market Cap
$2.87B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$2.87B
Return on Equity (ROE)
2.04%
TTM Avg
-6.01%
3Y Avg
-7.18%
5Y Avg
-5.00%
Market Cap
$2.69B
Return on Equity (ROE)
95.64%
TTM Avg
115.72%
3Y Avg
76.74%
5Y Avg
3213.80%
Market Cap
$2.69B
Return on Equity (ROE)
-56.91%
TTM Avg
-24.13%
3Y Avg
-9.83%
5Y Avg
-11.19%
Market Cap
$3.09B
Return on Equity (ROE)
-63.59%
TTM Avg
-115.27%
3Y Avg
-69.35%
5Y Avg
-25.98%
Market Cap
$2.64B
Return on Equity (ROE)
N/A
TTM Avg
9.38%
3Y Avg
9.38%
5Y Avg
9.38%
Market Cap
$2.64B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
Market Cap
$3.15B
Return on Equity (ROE)
12.93%
TTM Avg
-48.70%
3Y Avg
-135.42%
5Y Avg
-110.19%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.88B | -73.97% | -61.12% | -57.38% | -55.10% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 29.28% | 27.86% | 4.54% | -12.45% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 2.04% | -6.01% | -7.18% | -5.00% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 95.64% | 115.72% | 76.74% | 3213.80% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | -56.91% | -24.13% | -9.83% | -11.19% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | -63.59% | -115.27% | -69.35% | -25.98% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | N/A | 9.38% | 9.38% | 9.38% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -8.00% | -28.91% | -27.68% | -39.13% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 12.93% | -48.70% | -135.42% | -110.19% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | -61.24% | -42.47% | -32.58% | -25.72% |
ROE
-74.0%
ROA
-52.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -73.97% |
| 2026-03-31 | -52.22% |
| 2025-12-31 | -45.90% |
| 2025-09-30 | -61.26% |
| 2025-06-30 | -72.25% |
| 2025-03-31 | -54.88% |
| 2024-12-31 | -50.40% |
| 2024-09-30 | -41.74% |
| 2024-06-30 | -33.23% |
| 2024-03-31 | -53.84% |
| 2023-12-31 | -258.44% |
| 2023-09-30 | -136.89% |
| 2023-06-30 | -91.50% |
| 2023-03-31 | -73.04% |
| 2022-12-31 | -66.61% |
| 2022-09-30 | -72.50% |
| 2022-06-30 | -63.49% |
| 2022-03-31 | -47.53% |
| 2021-12-31 | -40.55% |
| 2021-09-30 | -30.46% |
| 2021-06-30 | -21.54% |
| 2021-03-31 | -16.00% |
| 2020-12-31 | -17.36% |
| 2020-09-30 | -9.87% |
| 2020-06-30 | -21.24% |
| 2020-03-31 | -149.27% |
| 2019-12-31 | -105.86% |
| 2017-12-31 | -65.39% |
| 2017-09-30 | -0.70% |
| 2017-06-30 | -6.12% |
| 2017-03-31 | -26.26% |
| 2016-12-31 | -60.92% |
| 2016-09-30 | -54.09% |
| 2016-06-30 | -39.34% |
| 2016-03-31 | 7.56% |
| 2015-12-31 | 1.71% |
| 2015-09-30 | 8.99% |
| 2015-06-30 | 9.18% |
| 2015-03-31 | -7.23% |
| 2014-12-31 | -2.05% |
| 2014-09-30 | -12.44% |
| 2014-06-30 | -11.12% |
| 2014-03-31 | -11.57% |
| 2013-12-31 | -16.11% |
| 2013-09-30 | 44.32% |
| 2013-06-30 | 41.61% |
| 2013-03-31 | 0.13% |
| 2012-12-31 | 3.48% |
| 2012-03-31 | -153.54% |
| 2011-12-31 | -147.93% |
| 2011-09-30 | -17.37% |
| 2011-06-30 | -14.89% |
| 2011-03-31 | -17.07% |
| 2010-12-31 | -8.52% |
| 2010-09-30 | -14.74% |
| 2010-06-30 | -21.48% |
| 2010-03-31 | -36.01% |
| 2009-12-31 | -43.49% |
| 2009-09-30 | -24.89% |
| 2009-06-30 | -2.20% |
| 2009-03-31 | 7.79% |
| 2008-12-31 | 3.85% |
| 2008-09-30 | 2.89% |
| 2008-06-30 | -6.13% |
| 2008-03-31 | 2.25% |
